| Title |
Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer
|
|---|---|
| Published in |
PLOS ONE, June 2012
|
| DOI | 10.1371/journal.pone.0038557 |
| Pubmed ID | |
| Authors |
Malek B. Hannouf, Chander Sehgal, Jeffrey Q. Cao, Joseph D. Mocanu, Eric Winquist, Gregory S. Zaric |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 27% |
| Researcher | 12 | 24% |
| Other | 6 | 12% |
| Student > Ph. D. Student | 4 | 8% |
| Student > Postgraduate | 4 | 8% |
| Other | 7 | 14% |
| Unknown | 3 | 6% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 47% |
| Economics, Econometrics and Finance | 7 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
| Social Sciences | 4 | 8% |
| Agricultural and Biological Sciences | 2 | 4% |
| Other | 6 | 12% |
| Unknown | 3 | 6% |